Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Zhengye Biotechnology Holding (ZYBT) Invested Capital (2023 - 2025)

Zhengye Biotechnology Holding has reported Invested Capital over the past 3 years, most recently at $52.4 million for Q4 2025.

  • Quarterly Invested Capital fell 11.81% to $52.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.4 million through Dec 2025, down 11.81% year-over-year, with the annual reading at $51.7 million for FY2025, 5.37% up from the prior year.
  • Invested Capital was $52.4 million for Q4 2025 at Zhengye Biotechnology Holding, up from $50.5 million in the prior quarter.
  • Over five years, Invested Capital peaked at $59.4 million in Q4 2024 and troughed at $50.5 million in Q2 2025.
  • The 3-year median for Invested Capital is $55.3 million (2023), against an average of $55.1 million.
  • Year-over-year, Invested Capital rose 2.11% in 2024 and then dropped 11.81% in 2025.
  • A 3-year view of Invested Capital shows it stood at $58.2 million in 2023, then increased by 2.11% to $59.4 million in 2024, then fell by 11.81% to $52.4 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Invested Capital are $52.4 million (Q4 2025), $50.5 million (Q2 2025), and $59.4 million (Q4 2024).